Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 2.640
Gan To Kagaku Ryoho ; 48(3): 443-445, 2021 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-33790182


This is the case of a 72-year-old man in whom multiple colorectal cancers including rectal and appendiceal cancers and synchronous S3 liver metastases were observed in 2014, and resection was performed in 2 stages. In 2017, a single recurrence was found in the liver S8, and he underwent a liver S8 sub-segmental resection. Implantation of a CV port for postoperative chemotherapy was planned. At the time of insertion, the catheter was punctured from the exterior portion of the left subclavian vein to avoid the pinch-off syndrome wherein the catheter is crushed between the clavicle and the first rib. Subsequently, FOLFOX therapy was started, but it was discontinued because of allergic symptoms, which appeared during the third course. Two years after the CV port was implanted, a catheter fracture was found on a chest X-ray performed during a regular visit. Since the detached catheter did not fall into the vein, it was possible to remove the port under fluoroscopy. When a catheter is implanted, even under ultrasound guidance, it is considered important to always keep in mind the possibility of a catheter fracture and to detect and respond to it early.

Cateterismo Venoso Central , Cateteres Venosos Centrais , Neoplasias Hepáticas , Idoso , Cateteres de Demora , Humanos , Neoplasias Hepáticas/tratamento farmacológico , Masculino , Recidiva Local de Neoplasia
An Acad Bras Cienc ; 93(3): e20200022, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33759956


In this study we apply methods to determine the tendency for thrombus formation in different central venous catheters (CVC) models associated with flow rate variation. To calculate the thrombogenic potential, we proposed a new numerical model of the platelet lysis index (PLI) equation. To compare the results of PLI and flow rate in different models of catheters, numerical calculations were performed on three different tips of CVC. The results showed that the PLI increases as a power function of the flow rate independent of the type of CVC. This study evidenced that the higher the blood flow rate used in the catheter, the greater the potential for thrombus formation. The PLI computed at the catheter outlet presented higher values when compared to the values computed at the vein outlet indicating that the blood flow through the CVC arterial lumen presents a proportionally larger thrombogenic potential when compared to the blood flow that leaves the vein towards the atrium. This finding may have consequences for clinical practice, since there is no specific flow value recommended in the catheter when the hemodialysis machine is turned on, and with this equation it was possible to demonstrate the thrombogenic potential that the flow rate can possibly offer.

Cateterismo Venoso Central , Cateteres Venosos Centrais , Cateterismo Venoso Central/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Humanos , Diálise Renal/efeitos adversos
Anticancer Res ; 41(3): 1547-1553, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33788748


BACKGROUND: We sought to identify the risk factors of totally implantable central venous access port (TICVAP)-related infections in patients with malignant disease. PATIENTS AND METHODS: Overall, 324 consecutive patients who received a TICVAP at our institution were retrospectively analysed. We further analysed cases of TICVAP-related complications. The risk factors for TICVAP-related infection were investigated using Cox regression hazard models. RESULTS: With a median TICVAP duration of 268 days (range=1-1,859 days), TICVAP-related complications were observed in 36 cases and infectious complications in late phase were the most common, seen in 19 cases (9.26%). A multivariate analysis showed that patients with head and neck malignancy (p<0.001) and patients who received TICVAP insertion in the upper arm (p<0.001) were independently at a higher risk for TICVAP-related infections. CONCLUSION: Patients with head and neck malignancy or TICVAP insertion in the upper arm have potentially increased risk for late-phase TICVAP-related infections.

Infecções Relacionadas a Cateter/etiologia , Cateteres de Demora/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Neoplasias/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Risco
Arch. argent. pediatr ; 119(1): 32-38, feb. 2021. tab, ilus
Artigo em Inglês, Espanhol | LILACS, BINACIS | ID: biblio-1147080


Introducción. En neonatología, más del 90 % de las trombosis venosas profundas están asociadas al uso de catéteres. El objetivo del estudio fue determinar la incidencia y los factores de riesgo relacionados con trombosis venosa profunda asociada a catéteres venosos centrales.Población y métodos. Estudio observacional analítico de cohorte prospectivo. Se incluyeron todos los catéteres venosos centrales mediante un muestreo no aleatorio consecutivo. El protocolo de pesquisa incluyó la evaluación clínica diaria y ecografía doppler (7-10 días luego de su colocación y/o a las 72 h de su retiro). Seguimiento: desde la colocación al retiro del catéter, fallecimiento o contrarreferencia del paciente. Se estimó densidad de incidencia cada 1000 días/catéter con sus intervalos de confianza (IC) del 95 % y factores de riesgo mediante análisis multivariado de Cox.Resultados. Se identificó trombosis en 22/264 catéteres. La densidad de incidencia de trombosis fue del 5,33 ‰ días/catéter (IC 95 %: 3,34-8,07). La cirugía cardiovascular y el uso de catéteres distintos a los epicutáneos resultaron ser factores de riesgo independientes para trombosis [Hazard Ratio: (3,8 [IC 95 %: 1,6-9] y 2,75 [IC 95 %: 1,17-6,45]).Conclusiones. La incidencia de trombosis venosa profunda asociada a catéteres venosos centrales fue de 5,33 cada 1000 días/catéter. El antecedente de procedimientos quirúrgicos cardiovasculares y el uso de catéteres distintos a los epicutáneos se asociaron con mayor riesgo de la complicación.

Introduction. In neonatology, more than 90 % of deep vein thromboses are related to catheter use. The objective of this study was to determine the incidence and risk factors associated with central venous catheter-related deep vein thrombosis.Population and methods. Observational and analytical study conducted in a prospective cohort. All central venous catheters were included using consecutive, non-random sampling. The screening protocol included a daily clinical examination and a Doppler ultrasound (7-10 days after insertion and/or 72 h after removal). Follow-up: from catheter insertion to catheter removal, death or patient counter-referral. The incidence density rate per 1000 catheter-days was estimated with its corresponding 95 % confidence intervals (CIs), and risk factors, using Cox multivariate analysis.Results. Thrombosis was identified in 22/264 catheters. The incidence density rate of thrombosis was 5.33 ‰ catheter-days (95 % CI: 3.34-8.07). Cardiovascular surgery and and the use of central catheters others than peripherally inserted ones, were independent risk factors for thrombosis (hazard ratio: 3.8 [95 % CI: 1.6-9] and 2.75 [95 % CI: 1.17-6.45]).Conclusions. The incidence of central venous catheter-related deep vein thrombosis was 5.33 per 1000 catheter-days. A history of cardiovascular surgical procedures and and the use of central catheters others than peripherally inserted ones, were associated with a higher risk of this complication.

Humanos , Masculino , Feminino , Recém-Nascido , Trombose Venosa , Cateteres Venosos Centrais/efeitos adversos , Incidência , Estudos Prospectivos , Fatores de Risco , Neonatologia
Medicine (Baltimore) ; 100(2): e24156, 2021 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-33466189


ABSTRACT: Patients with colorectal cancer (CRC) treated with curative intent surgery undergo continuous fluorouracil (5-FU) infusion-based chemotherapy using totally implantable central venous port system (TICVPS) in cases with high risk of recurrence. Approximately 30% of patients relapse after therapy completion, especially within 2 years. Hence, many patients with high risk CRC keep the TICVPS for 6 to 24 months after treatment with regular intervals of TICVPS flushing. However, little is known about the proper interval duration of the port. The aim of this study is to investigate whether a 3 months extended interval is safe and if port maintenance is feasible.A retrospective cohort was compiled of patients with CRC who underwent curative intent surgery and perioperative chemotherapy using TICVPS between 2010 and 2017. The primary end point was TICVPS maintenance rate, including maintenance of TICVPS for at least 6 months, planned TICVPS removal after 6 months, and regaining the use of TICVPS at the time of recurrence.A total of 214 patients with CRC underwent curative intent treatments during the study period. Among them, 60 patients were excluded, including 6 patients for early recurrence within 3 months and 54 patients with violation of flushing interval. Finally, 154 patients were analyzed. Mean flushing interval was 98.4 days (95% confidence interval [CI], 96.2-100.6; range, 60-120). In December 2018, 35 patients kept the TICVPS, 92 patients had planned removal, 25 patients reused the TICVPS, and 2 patients had to unexpectedly remove the TICVPS due to site infection and pain. Thus, the functional TICVPS maintenance rate was 98.8% (152/154). Thirty-eight patients relapsed, and 30 patients were treated with intravenous chemotherapy. Among them, 25 patients (83.3%) reused the maintained TICVPS without a reinsertion procedures.Our study demonstrated that 3-month interval access and flushing is safe and feasible for maintaining TICVPS during surveillance of patients with CRC. An extended interval up to 3 months can be considered because it is compatible with CRC surveillance visit schedules.

Cateterismo Venoso Central/normas , Cateteres Venosos Centrais/tendências , Tratamento Farmacológico/instrumentação , Adulto , Idoso , Antineoplásicos/uso terapêutico , Infecções Relacionadas a Cateter/prevenção & controle , Cateterismo Venoso Central/instrumentação , Cateterismo Venoso Central/enfermagem , Neoplasias Colorretais/tratamento farmacológico , Neoplasias Colorretais/cirurgia , Estudos de Viabilidade , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo
Rev Lat Am Enfermagem ; 29: e3385, 2021.
Artigo em Inglês, Português, Espanhol | MEDLINE | ID: mdl-33439945


OBJECTIVE: to evaluate the effectiveness of the 50 IU/mL heparin solution compared to the 0.9% isotonic saline solution in preventing occlusion of the double lumen Hickman® catheter, 7 and 9 French, in patients undergoing hematopoietic stem cell transplantation. METHOD: a triple-blind randomized clinical trial. 17 double-lumen catheters (heparin group: n=7 and 0.9% isotonic saline group: n=10) were analyzed in which the two catheter routes were evaluated separately, totaling 34 lumens. The outcome variables were occlusion without reflux and complete occlusion. Descriptive analyses were performed using the Chi-square test and, of survival, according to the Kaplan-Meier test. RESULTS: the mean number of days until the occlusion outcome was 52 in the heparin group and 13.46 in the 0.9% isotonic saline group in the white catheter route (p<0.001). In the red route, the mean follow-up days in the heparin group were 35.29, with no occlusion and 22.30 in the 0.9% isotonic saline group until the first occlusion (p=0.030). CONCLUSION: blocking with 50 IU/mL heparin solution is more effective than 0.9% isotonic saline in preventing occlusion of the Hickman® catheter. Brazilian Registry of Clinical Trials: RBR-3ht499.

Cateterismo Venoso Central , Cateteres Venosos Centrais , Anticoagulantes , Brasil , Cateteres de Demora/efeitos adversos , Distribuição de Qui-Quadrado , Heparina , Humanos
Artigo em Alemão | MEDLINE | ID: mdl-33412604


Children with complex diseases often need central venous catheter, not only for intraoperative use, but also for parenteral nutrition, multiple blood draw due to lab examination and to administer drugs that cannot be given via peripheral lines. Whereas the landmark driven vascular access was teached for years, nowadays the routine use of ultrasound based techniques can be called the gold standard. This article highlights standard locations for central venous access like cannulation of the internal jugular vein as well as novel alternatives such as the cannulation of the brachiocephalic vein. The correct insertion depth of central lines is essential to avoid serious complications. Several different formulas are available and can be used. Independent of the used formula, you have to make sure that complications due to incorrect depth of central venous line are a topic of the past. Finally, important tips and tricks to avoid failure and serious complications are discussed.

Cateterismo Venoso Central , Cateteres Venosos Centrais , Cateterismo Venoso Central/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Criança , Humanos , Veias Jugulares/diagnóstico por imagem , Ultrassonografia
Cochrane Database Syst Rev ; 1: CD012899, 2021 01 27.
Artigo em Inglês | MEDLINE | ID: mdl-33501650


BACKGROUND: Patients with chronic kidney disease (CKD) who require urgent initiation of dialysis but without having a permanent dialysis access have traditionally commenced haemodialysis (HD) using a central venous catheter (CVC). However, several studies have reported that urgent initiation of peritoneal dialysis (PD) is a viable alternative option for such patients. OBJECTIVES: This review aimed to examine the benefits and harms of urgent-start PD compared to HD initiated using a CVC in adults and children with CKD requiring long-term kidney replacement therapy. SEARCH METHODS: We searched the Cochrane Kidney and Transplant Register of Studies up to 25 May 2020 for randomised controlled trials through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and For non-randomised controlled trials, MEDLINE (OVID) (1946 to 11 February 2020) and EMBASE (OVID) (1980 to 11 February 2020) were searched. SELECTION CRITERIA: All randomised controlled trials (RCTs), quasi-RCTs and non-RCTs comparing urgent-start PD to HD initiated using a CVC. DATA COLLECTION AND ANALYSIS: Two authors extracted data and assessed the quality of studies independently. Additional information was obtained from the primary investigators. The estimates of effect were analysed using random-effects model and results were presented as risk ratios (RR) with 95% confidence intervals (CI). The GRADE framework was used to make judgments regarding certainty of the evidence for each outcome. MAIN RESULTS: Overall, seven observational studies (991 participants) were included: three prospective cohort studies and four retrospective cohort studies. All the outcomes except one (bacteraemia) were graded as very low certainty of evidence given that all included studies were observational studies and few events resulting in imprecision, and inconsistent findings. Urgent-start PD may reduce the incidence of catheter-related bacteraemia compared with HD initiated with a CVC (2 studies, 301 participants: RR 0.13, 95% CI 0.04 to 0.41; I2 = 0%; low certainty evidence), which translated into 131 fewer bacteraemia episodes per 1000 (95% CI 89 to 145 fewer). Urgent-start PD has uncertain effects on peritonitis risk (2 studies, 301 participants: RR 1.78, 95% CI 0.23 to 13.62; I2 = 0%; very low certainty evidence), exit-site/tunnel infection (1 study, 419 participants: RR 3.99, 95% CI 1.2 to 12.05; very low certainty evidence), exit-site bleeding (1 study, 178 participants: RR 0.12, 95% CI 0.01 to 2.33; very low certainty evidence), catheter malfunction (2 studies; 597 participants: RR 0.26, 95% CI: 0.07 to 0.91; I2 = 66%; very low certainty evidence), catheter re-adjustment (2 studies, 225 participants: RR: 0.13; 95% CI 0.00 to 18.61; I2 = 92%; very low certainty evidence), technique survival (1 study, 123 participants: RR: 1.18, 95% CI 0.87 to 1.61; very low certainty evidence), or patient survival (5 studies, 820 participants; RR 0.68, 95% CI 0.44 to 1.07; I2 = 0%; very low certainty evidence) compared with HD initiated using a CVC. Two studies using different methods of measurements for hospitalisation reported that hospitalisation was similar although one study reported higher hospitalisation rates in HD initiated using a catheter compared with urgent-start PD. AUTHORS' CONCLUSIONS: Compared with HD initiated using a CVC, urgent-start PD may reduce the risk of bacteraemia and had uncertain effects on other complications of dialysis and technique and patient survival. In summary, there are very few studies directly comparing the outcomes of urgent-start PD and HD initiated using a CVC for patients with CKD who need to commence dialysis urgently. This evidence gap needs to be addressed in future studies.

Cateteres Venosos Centrais , Tratamento de Emergência/métodos , Diálise Renal/métodos , Insuficiência Renal Crônica/terapia , Tempo para o Tratamento , Bacteriemia/epidemiologia , Bacteriemia/prevenção & controle , Viés , Infecções Relacionadas a Cateter/epidemiologia , Infecções Relacionadas a Cateter/prevenção & controle , Tratamento de Emergência/efeitos adversos , Tratamento de Emergência/instrumentação , Tratamento de Emergência/mortalidade , Hospitalização/estatística & dados numéricos , Humanos , Estudos Observacionais como Assunto/estatística & dados numéricos , Diálise Peritoneal/efeitos adversos , Diálise Peritoneal/instrumentação , Diálise Peritoneal/métodos , Diálise Peritoneal/mortalidade , Peritonite/epidemiologia , Diálise Renal/efeitos adversos , Diálise Renal/instrumentação , Diálise Renal/mortalidade , Insuficiência Renal Crônica/mortalidade
Rev. latinoam. enferm. (Online) ; 29: e3385, 2021. graf
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: biblio-1150006


Objective: to evaluate the effectiveness of the 50 IU/mL heparin solution compared to the 0.9% isotonic saline solution in preventing occlusion of the double lumen Hickman® catheter, 7 and 9 French, in patients undergoing hematopoietic stem cell transplantation. Method: a triple-blind randomized clinical trial. 17 double-lumen catheters (heparin group: n=7 and 0.9% isotonic saline group: n=10) were analyzed in which the two catheter routes were evaluated separately, totaling 34 lumens. The outcome variables were occlusion without reflux and complete occlusion. Descriptive analyses were performed using the Chi-square test and, of survival, according to the Kaplan-Meier test. Results: the mean number of days until the occlusion outcome was 52 in the heparin group and 13.46 in the 0.9% isotonic saline group in the white catheter route (p<0.001). In the red route, the mean follow-up days in the heparin group were 35.29, with no occlusion and 22.30 in the 0.9% isotonic saline group until the first occlusion (p=0.030). Conclusion: blocking with 50 IU/mL heparin solution is more effective than 0.9% isotonic saline in preventing occlusion of the Hickman® catheter. Brazilian Registry of Clinical Trials: RBR-3ht499.

Objetivo: avaliar a efetividade da solução de heparina 50 UI/mL comparada à solução salina isotônica 0,9% na prevenção de oclusão do Cateter de Hickman® duplo lúmen, 7 e 9 french, em pacientes submetidos ao transplante de células-tronco hematopoéticas. Método: ensaio clínico randomizado triplo cego. Foram analisados 17 cateteres duplo lúmen (grupo heparina n=7 e grupo solução salina isotônica 0,9% n=10) nos quais as duas vias do cateter foram avaliadas separadamente, totalizando 34 lúmens. As variáveis de desfecho foram oclusão sem refluxo e oclusão completa. As análises descritivas foram realizadas mediante o teste Qui-quadrado e, de sobrevida, sob o teste de Kaplan-Meier. Resultados: a média de dias até o desfecho oclusão foi de 52 no grupo heparina e de 13,46 no grupo solução salina isotônica 0,9% na via branca do cateter (p<0,001). Na via vermelha, a média de dias de acompanhamento do grupo heparina foi de 35,29, sem ocorrência de oclusão, e de 22,30 no grupo solução salina isotônica 0,9% até a primeira oclusão (p=0,030). Conclusão: o bloqueio com solução de heparina 50 UI/mL é mais efetivo em relação à solução salina isotônica 0,9% na prevenção da oclusão do Cateter de Hickman®. Registro Brasileiro de Ensaios Clínicos: RBR-3ht499.

Objetivo: evaluar la eficacia de la solución de heparina 50 UI/mL comparada con la solución salina isotónica al 0,9% para prevenir oclusiones en catéteres de Hickman® doble lumen, 7 y 9 French, en pacientes sometidos a trasplante de células madre hematopoyéticas. Método: ensayo clínico aleatorizado triple ciego. Se analizaron 17 catéteres de doble lumen (grupo de heparina: n=7 y grupo de solución salina isotónica al 0,9%: n=10) en los que se evaluaron por separado las dos vías del catéter, totalizando 34 lúmenes. Las variables de resultado fueron oclusión sin reflujo y oclusión completa. Los análisis descriptivos se realizaron mediante el test de Chi-cuadrado y, los de sobrevida, con el test de Kaplan-Meier. Resultados: la media de días hasta el resultado de oclusión fue de 52 en el grupo de heparina y de 13,46 en el grupo de la solución salina isotónica al 0,9% en la vía blanca del catéter (p<0,001). En la vía roja, la media de días de seguimiento del grupo de heparina fue de 35,29 sin oclusión y de 22,30 en el del grupo solución salina isotónica al 0,9% hasta la primera oclusión (p=0,030). Conclusión: el bloqueo con solución de heparina 50 UI/mL es más eficaz en relación con la solución salina isotónica al 0,9% para prevenir oclusiones en catéteres de Hickman®. Registro Brasileño de Ensayos Clínicos: RBR 3ht499.

Efetividade , Heparina , Cloreto de Sódio , Ceco , Ensaio Clínico Controlado Aleatório , Assistência ao Convalescente , Prevenção de Doenças , Estimativa de Kaplan-Meier , Enfermagem Baseada em Evidências , Cateteres , Obstrução do Cateter , Cateteres Venosos Centrais
Vasc Endovascular Surg ; 55(3): 228-233, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33308082


BACKGROUND: Thoracic central venous obstruction (TCVO) is a common condition which can impact the ability to achieve central venous access (CVA) in patients on hemodialysis. The Surfacer® Inside-Out® Catheter Access System is designed to enable repeated right-side central venous access in patients with TCVO. METHODS: We retrospectively analyzed medical records of 10 dialysis patients who presented with TCVO and underwent the Inside-Out procedure with the Surfacer System to obtain CVA between 2017 and 2020. Patient demographics, hemodialysis vascular access history, and procedural data were identified and analyzed. The mean patient age was 62.4 ± 19.6 years (25.9-89.1 years) with 7 of the 10 patients being male. Eight patients (80.0%) were diagnosed with chronic kidney disease with time on hemodialysis ranging from 3 to 13 years. The remaining 2 required CVA to treat acute-on-chronic kidney injury due to septic shock. Patients in our series had a mean of 2.8 ± 1.6 previous catheters placed prior to the Surfacer procedure. RESULTS: CVA was achieved in all 10 patients with 1 patient requiring a second attempt to achieve access due to the inability to initially traverse the iliac vein with the device, possibly due to a history of kidney transplantation. One multimorbid patient died shortly after the successful procedure, possibly due to cardiac decompensation. Mean total procedure time for the 7 patients having only dialysis catheter placement using the Surfacer device was 67.2 ± 19.1 minutes (49-103 minutes). The remaining 3 patients received a Hemodialysis Reliable Outflow (HeRO) graft in conjunction with the Inside-Out procedure. All vascular accesses functioned properly during the immediate time period following placement. No adverse events associated with the use of Surfacer device were encountered. CONCLUSIONS: Data presented from our patient series confirms the effectiveness of the Surfacer System to safely achieve CVA in dialysis patients with TCVOs with a history of multiple catheter placements.

Cateterismo Venoso Central/instrumentação , Cateteres de Demora , Cateteres Venosos Centrais , Nefropatias/terapia , Diálise Renal , Tórax/irrigação sanguínea , Doenças Vasculares/complicações , Veias , Adulto , Idoso , Idoso de 80 Anos ou mais , Cateterismo Venoso Central/efeitos adversos , Desenho de Equipamento , Feminino , Humanos , Nefropatias/complicações , Nefropatias/diagnóstico , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento , Doenças Vasculares/diagnóstico por imagem , Veias/diagnóstico por imagem
Adv Chronic Kidney Dis ; 27(5): 377-382, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-33308502


Acute kidney injury is a common complication in hospitalized patients with coronavirus disease 2019. Similar to acute kidney injury associated with other conditions such as sepsis and cardiac surgery, morbidity and mortality are much higher in patients with coronavirus disease 2019 who develop acute kidney injury, especially in the intensive care unit. Management of coronavirus disease 2019-associated acute kidney injury with kidney replacement therapy should follow existing recommendations regarding modality, dose, and timing of initiation. However, patients with coronavirus disease 2019 are very hypercoagulable, and close vigilance to anticoagulation strategies is necessary to prevent circuit clotting. During situations of acute surge, where demand for kidney replacement therapy outweighs supplies, conservative measures have to be implemented to safely delay kidney replacement therapy. A collaborative effort and careful planning is needed to conserve dialysis supplies, to ensure that treatment can be safely delivered to every patient who will benefit for kidney replacement therapy.

Lesão Renal Aguda/terapia , Anticoagulantes/uso terapêutico , Terapia de Substituição Renal/métodos , Trombofilia/tratamento farmacológico , /sangue , Cateterismo Venoso Central , Cateteres Venosos Centrais , Ácido Cítrico/uso terapêutico , Terapia de Substituição Renal Contínua/métodos , Soluções para Hemodiálise/provisão & distribução , Hemoperfusão/métodos , Heparina/uso terapêutico , Humanos , Terapia de Substituição Renal Híbrida/métodos , Terapia de Substituição Renal Intermitente/métodos , Rins Artificiais/provisão & distribução , Tempo de Tromboplastina Parcial , Terapia de Substituição Renal/instrumentação , Capacidade de Resposta ante Emergências , Trombofilia/sangue
Texto & contexto enferm ; 29: e20190107, Jan.-Dec. 2020. tab
Artigo em Inglês | LILACS, BDENF - Enfermagem | ID: biblio-1145162


ABSTRACT Objective: to evaluate the compliance of the nursing team's care practice in handling the central vascular catheter when changing dressings and equipment in an intensive care unit. Method: a descriptive, prospective, and observational research study. Data collection was conducted from January to March 2016 in an Intensive Care unit of a public hospital in Sergipe, northeastern Brazil. Direct observation of the professionals was conducted using a safe checklist. Descriptive statistics was used to determine the process indicators, and inferential statistics to determine the association between the variables, using the chi-square and Fisher's tests, with a 5% significance level. Results: 534 procedures corresponding to the exchange of equipment and dressings were observed, corresponding to 5,073 actions. As for the change of equipment, 2,136 actions were evaluated, most of them carried out by nursing technicians. Of the eight actions evaluated in each procedure, only two (25%) reached the desired compliance, with a positivity index between 90% and 99%. Regarding the dressing change, 2,937 actions were evaluated, all of which were performed by nurses. Of the eleven evaluated actions, eight (72%) achieved desired compliance, with a positivity index between 80% and 100%. Conclusion: the results analyzed are far from the desired compliances, demonstrating the need to implement strategies to ensure the safety culture during the care provided.

RESUMEN Objetivo: evaluar la conformidad de la práctica asistencial del equipo de Enfermería en la manipulación del catéter vascular central al momento de cambiar vendajes y equipos en una Unidad de Cuidados Intensivos. Método: investigación descriptiva, prospectiva y de observación. La recolección de datos tuvo lugar entre enero y marzo de 2016 en una Unidad de Cuidados Intensivos de un hospital público de Sergipe, noreste de Brasil. Se realizó una observación directa de los profesionales por medio de una checklist de verificación segura. Se utilizó análisis descriptivo para determinar los indicadores de proceso, y estadística inferencial para determinar la asociación entre las variables, usando las pruebas de chi-cuadrado y de Fisher, con un nivel de significancia del 5%. Resultados: se observaron 534 procedimientos correspondientes al cambio de equipos y vendajes, lo que correspondió a 5.073 acciones. En relación al cambio de equipos, se evaluaron 2.136 acciones, la mayoría realizadas por técnicos en Enfermería. De las ocho acciones evaluadas en cada procedimiento, solamente dos (25%) alcanzaron la conformidad deseada, con un índice de positividad del 90% al 99%. En relación con el cambio de vendajes, se evaluaron 2.937 acciones, todas ejecutadas por Enfermeros. De las once acciones evaluadas, ocho (72%) alcanzaron la conformidad deseada, con un índice de positividad del 80% al 100%. Conclusión: los resultados analizados distan de los niveles de conformidad deseados, lo que demuestra la necesidad de implementar estrategias para garantizar la cultura de la seguridad durante la atención provista.

RESUMO Objetivo: avaliar a conformidade da prática assistencial da equipe de enfermagem no manuseio do cateter vascular central na troca de curativos e de equipos em unidade de terapia intensiva. Método: pesquisa descritiva, prospectiva, observacional. A coleta de dados ocorreu de janeiro a março de 2016 em uma unidade de terapia intensiva de um hospital público do Sergipe, nordeste do Brasil. Realizada observação direta dos profissionais utilizando checklist de verificação segura. A análise descritiva foi utilizada para determinação dos indicadores de processo, e a estatística inferencial para determinar a associação entre as variáveis, usando os testes de Qui-Quadrado e Fisher, com nível de significância de 5%. Resultados: observados 534 procedimentos correspondentes a troca de equipos e curativos, correspondendo a 5073 ações. Quanto à troca de equipo 2.136 ações foram avaliadas, a maioria realizadas por técnicos em Enfermagem. Das oito ações avaliadas em cada procedimento, apenas duas (25%) alcançaram conformidade almejada, com índice de positividade entre 90% e 99%. Referente a troca de curativo, 2.937 ações foram avaliadas, sendo todas executadas por Enfermeiros. Das onze ações avaliadas, oito (72%) alcançaram conformidade desejada, com índice de positividade entre 80% e 100%. Conclusão: os resultados analisados estão distantes das conformidades almejadas, demonstrando a necessidade de implementação estratégias para garantir a cultura de segurança durante a assistência prestada.

Humanos , Equipe de Assistência ao Paciente , Infecções Relacionadas a Cateter , Segurança do Paciente , Cateteres Venosos Centrais
Rev. enferm. UERJ ; 28: e42285, jan.-dez. 2020.
Artigo em Inglês, Português | LILACS, BDENF - Enfermagem | ID: biblio-1120154


Objetivo: comparar o custo entre coberturas com filme transparente versus gaze estéril e fita adesiva microporosa em curativos de acesso venoso central. Método: estudo estatístico, prospectivo, observacional, com abordagem quantitativa à luz da avaliação econômica de saúde. Foram avaliadas 109 coberturas com filme e 168 com gaze, durante 27 dias. Na análise utilizouse o Software Tree Age para se calcular a probabilidade de cada decisão. Resultado: a média de uso das coberturas por dia foi de 2,22 inserções cobertas com filme e 3,43 com gaze. Houve necessidade de troca extra em 38 (23%) das coberturas com gaze e em 16 (15%) das coberturas com filme transparente. Observou-se custo final médio para gaze (R$389,44) 3,7 vezes maior que o filme transparente (R$104,95) durante o período estudado. Conclusão: cobertura com filme transparente tem menor custo quando comparado com cobertura com gaze estéril.

Objective: to compare the cost of transparent film and sterile gauze fixed by microporous adhesive tape in central venous access dressings. Method: quantitative, prospective, observational, statistical study in the light of health economics. A total of 109 film and 168 gauze covers were evaluated for 27 days. Tree Age software was used to calculate the probability of each decision. Results: coverings used per day averaged 2.22 with transparent film-covered inserts and 3.43 with gauze. Additional changes were necessary in 38 (23%) coverings with gauze and 16 (15%) with transparent film. During the study period, the average final cost of gauze (R$ 389.44) was 3.7 times higher than transparent film (R$104.95). Conclusion: transparent film dressing is less expensive than sterile gauze covering.

Objetivo: comparar el costo de la película transparente y la gasa estéril fijada con cinta adhesiva microporosa en apósitos de acceso venoso central. Método: estudio cuantitativo, prospectivo, observacional, estadístico a la luz de la economía de la salud. Se evaluaron un total de 109 películas y 168 cubiertas de gasa durante 27 días. Se utilizó el software Tree Age para calcular la probabilidad de cada decisión. Resultados: los recubrimientos utilizados por día promediaron 2,22 con inserciones transparentes recubiertas con película y 3,43 con gasas. Fueron necesarios cambios adicionales en 38 (23%) revestimientos con gasa y 16 (15%) con película transparente. Durante el período de estudio, el costo final promedio de la gasa (R $ 389,44) fue 3,7 veces superior al de la película transparente (R $ 104,95). Conclusión: el apósito de película transparente es menos costoso que el recubrimiento de gasa estéril.

Humanos , Avaliação em Saúde/economia , Cateteres Venosos Centrais , Curativos Oclusivos/economia , Brasil , Árvores de Decisões , Estudos Prospectivos , Custos e Análise de Custo , Estudo Observacional , Curativos Oclusivos/estatística & dados numéricos
Medicine (Baltimore) ; 99(45): e23091, 2020 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-33157980


BACKGROUND: Peripherally inserted central catheter (PICC) is closely related to venous thromboembolism (VTE). It is a common complication of hospitalized patients, and its etiology is complex. How to prevent the occurrence of VTE is the focus of clinical work. In order to provide basis for individual prevention and accurate treatment of VTE, the purpose of this study was to explore the relationship between ABO blood group and the risk of VTE in cancer patients associated with PICC through meta-analysis. METHODS: Electronic databases, including Embase, Cochrane Library, Pubmed, Chinese databases SinoMed, Chinese National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), and Wanfang Data, were searched for case-control studies of ABO blood group and PICC-related VTE in cancer patients. The languages were limited to Chinese and English. Two reviewers were responsible for the selection of the study, the extraction of data and the evaluation of the quality of the research. All statistical analyses were carried out with Review Manager 5.3 and Stata 14.0. RESULTS: The results of this meta-analysis would be published in peer-reviewed journals. CONCLUSION: This study provided evidence to support the relationship between ABO blood group and the risk of PICC-related VTE in cancer patients. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/6DPFG.

Sistema ABO de Grupos Sanguíneos , Cateteres Venosos Centrais/efeitos adversos , Metanálise como Assunto , Neoplasias/sangue , Neoplasias/tratamento farmacológico , Projetos de Pesquisa , Revisões Sistemáticas como Assunto , Trombose Venosa/epidemiologia , Trombose Venosa/etiologia , Cateterismo Venoso Central/métodos , Humanos , Medição de Risco
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 38(9): 425-430, nov. 2020. tab
Artigo em Inglês | IBECS | ID: ibc-198626


INTRODUCTION: Data concerning the use of peripherally inserted central catheters (PICC) for the administration of intravenous (IV) antimicrobials in the acute care setting is scarce. METHODS: We performed a single-center retrospective case-control study (1:1). Case subjects were defined as patients who received IV antimicrobial treatment through a PICC line placed and maintained by specifically trained nurses (PICC group). Control subjects were defined as patients who received antimicrobial therapy by a peripheral or a central venous catheter (CVC) (control group). Control subjects were matched by type of antimicrobial, causative microorganism of the infection that was being treated and duration of treatment. An event leading to undesired catheter removal (ELUCR) was defined as any circumstance which lead to the removal of the indwelling catheter other than the completion of the scheduled course of antimicrobial therapy. RESULTS: The study included 50 patients in each group. The total follow-up time was 1376 catheter-days for the PICC group and 1362 catheter-days for the control group. We observed a significantly lower incidence of ELUCR in the PICC group (0.2 versus 7.7 events per 100 catheter-days; P < 0.001). When the incidence of ELUCR was analyzed according to the duration of indwelling catheterisation for each type of catheter (divided into one-week intervals), differences between both groups were also significant (P-values ≤ 0.001 for the first three weeks of treatment). During the second week of IV treatment, only one patient in the PICC group (2.1%) developed an ELUCR compared to 19 (38.8%) in the control group (P < 0.001). CONCLUSIONS: A PICC placed and maintained by a dedicated nursing team is an excellent alternative to peripheral venous catheters or CVCs for administrating antimicrobial therapy for both short and long periods of treatment

INTRODUCCIÓN: Existe escasa información disponible sobre el empleo de catéteres venosos centrales de inserción periférica (PICC en sus siglas en inglés) para la administración de antimicrobianos por vía intravenosa (IV) en la atención a pacientes con procesos agudos. MÉTODOS: Realizamos un estudio unicéntrico retrospectivo de casos y controles (1:1). Los casos estaban constituidos por pacientes que recibieron tratamiento antimicrobiano IV a través de un catéter tipo PICC que fue insertado y cuidado por un equipo de enfermería especialmente entrenado a tal efecto (grupo PICC). Los controles estaban constituidos por pacientes que recibieron el tratamiento antimicrobiano a través de un catéter venoso periférico o a través de un catéter venoso central (CVC) (grupo control). Los controles fueron emparejados con los casos considerando el tipo de antimicrobiano administrado, el microorganismo causal de la infección que se estaba tratando y la duración del tratamiento. Se definió como un evento que condujo a la retirada no deseada del catéter (ECRDC) a cualquier circunstancia que obligara a la retirada del catéter insertado antes del tiempo programado para completar el tratamiento antimicrobiano establecido. RESULTADOS: El estudio incluyó 50 pacientes en cada grupo. El tiempo total de seguimiento fue de 1.376 días de catéter en el grupo PICC y de 1.362 días de catéter en el grupo control. Se observó una incidencia de ECRDC significativamente menor en el grupo PICC que en el grupo control (0,2 versus 7,7 eventos por cada 100 días de catéter; P < 0,001). Cuando la incidencia de ECRDC se analizó según la duración del tiempo de inserción de cada tipo de catéter (dividido en intervalos de una semana), se pudo constatar que las diferencias entre ambos grupos también eran significativas (P ≤ 0.001 para las tres primeras semanas de tratamiento). Durante la segunda semana de tratamiento IV, solamente un paciente en el grupo PICC (2,1%) desarrolló un ECRDC en comparación con 19 (38,8%) en el grupo control (P (P < 0,001). CONCLUSIONES: Un catéter tipo PICC insertado y cuidado por un equipo de enfermería entrenado es una excelente alternativa a los catéteres venosos periféricos o a los CVC para la administración de antimicrobianos tanto para periodos cortos como para periodos largos de tiempo

Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Cateterismo Periférico/enfermagem , Cateteres Venosos Centrais , Anti-Infecciosos/administração & dosagem , Equipe de Enfermagem , Estudos Retrospectivos , Remoção de Dispositivo/efeitos adversos , Cateterismo Periférico/efeitos adversos , Resultado do Tratamento , Fatores de Tempo , Fatores de Risco , Reprodutibilidade dos Testes , Cateteres de Demora/efeitos adversos
Artigo em Alemão | MEDLINE | ID: mdl-33053590


The removal of a central venous catheter on a ward leads to a paradox air embolism in a 53-year-old male patient with an unknown ventricular septal defect. The patient undergoes sufficient cardiopulmonary resuscitation but suffers from a multiple stroke syndrome with serious neurological deficits.

Cateterismo Venoso Central , Cateteres Venosos Centrais , Embolia Aérea , Acidente Vascular Cerebral , Cateterismo Venoso Central/efeitos adversos , Cateteres Venosos Centrais/efeitos adversos , Infarto Cerebral , Embolia Aérea/diagnóstico por imagem , Embolia Aérea/etiologia , Embolia Aérea/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Acidente Vascular Cerebral/etiologia , Acidente Vascular Cerebral/terapia
Enferm. clín. (Ed. impr.) ; 30(5): 295-301, sept.-oct. 2020. graf, tab
Artigo em Espanhol | IBECS | ID: ibc-196771


OBJETIVO: Analizar la incidencia de complicaciones relacionadas con el catéter central de inserción periférica y la viabilidad de la infusión de las células madre hematopoyéticas mediante bombas de perfusión volumétrica. MÉTODO: Estudio descriptivo prospectivo que incluye a todos los pacientes que recibieron un trasplante hematopoyético en el Servicio de Hematología del Hospital Clínico de Valencia entre enero y diciembre de 2016 (n=73). A todos se les colocó un catéter central de inserción periférica. Se utilizó el programa informático SPSS® V.22 para realizar el análisis descriptivo de las principales variables utilizando un intervalo de confianza del 95%. Se realizó el análisis de la t de Student para comparar las medias de 2 muestras independientes suponiendo varianzas desiguales. RESULTADO: El 63% (n=73) de los catéteres se mantuvieron sin problemas durante todo el procedimiento. La principal causa de retirada del catéter fue la fiebre de origen desconocido (28,8%). La mediana de días para la recuperación hematológica en el trasplante autólogo fue de 12,5 días y en el alogénico de 15 días. CONCLUSIONES: El catéter central de inserción periférica presenta pocas complicaciones relacionadas con la inserción. La administración de las células hematopoyéticas a través de este tipo de catéteres y con bombas de perfusión volumétrica no supone un retraso en la recuperación hematológica. Se constata una buena aceptación por parte del paciente

AIMS: To analyze the incidence of complications related to the central peripheral insertion catheter and the viability of the infusion of haematopoietic stem cells through volumetric perfusion pumps. METHOD: Prospective descriptive study that includes all patients who received a haematopoietic transplant in the Haematology Service of the Hospital Clínico de Valencia between January and December 2016 (n=73). All of them received a central peripheral insertion catheter. SPSS™ v22 was used to perform the descriptive analysis of the main variables using a confidence interval of 95%. The student's t-test was used to compare the means of two independent samples assuming unequal variances. RESULTS: The 63% (n=73) of the catheters remained without problems throughout the procedure. Fever of unknown origin (28.8%) was the main cause of catheter removal. The median number of days for haematological recovery was 12.5 for the autologous transplants and 15 for the allogeneic transplants. CONCLUSIONS: The central peripheral insertion catheter presents few complications related to insertion. The administration of haematopoietic cells through these catheters with volumetric perfusion pumps does not imply a delay in haematological recovery. Good acceptance by the patient is confirmed

Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso , Cateteres Venosos Centrais/efeitos adversos , Cateterismo Periférico/efeitos adversos , Cateterismo Periférico/instrumentação , Transplante de Células-Tronco Hematopoéticas/métodos , Infecções Relacionadas a Cateter/etiologia , Cateterismo Venoso Central/enfermagem , Estudos Prospectivos , Febre/complicações , Bombas de Infusão , Infecções Relacionadas a Cateter/enfermagem , Satisfação do Paciente , Transplante Homólogo/métodos , Transplante Autólogo/métodos , Bacteriemia/diagnóstico